icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
No Resistance to Tenofovir Alafenamide Detected
Through 96 Weeks of Treatment in Patients with Chronic Hepatitis B

 
 
  Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
 
Henry Lik-Yuen Chan1, Patrick Marcellin2, Calvin Q. Pan3, Andrea L Cathcart4, Neeru Bhardwaj4, Yang Liu4, Stephanie Cox4, Bandita Parhy4, Eric Zhou4, John F Flaherty4, Anuj Gaggar4, Shalimar5, Namiki Izumi6, Young-Suk Lim7
 
1Department of Medicine and Therapeutics, Institute of Digestive Disease and State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong; 2Service d'Hépatologie, Hopital Beaujon, Clichy, France; 3Division of Gastroenterology and Hepatology, Department of Medicine, NYU Langone Medical Center, NYU School of Medicine, New York, NY; 4Gilead Sciences, Foster City, CA; 5Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India; 6Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan; 7Department of Gastroenterology, Asan Medical Center, Seoul, Korea

1025171

1025172

1025173

1025174

1025175

1025176